Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis

<div>The PK profiles for an anti-mICOSL VNAR-Fc CC3-Fc dosed at 4 mg/kg i.v. and s.c. Composite profiles derived from 6 animals per route of administration: curve-fitted subcutaneously (a) and curve-fitted intravenously (b).</div>

Journal of Immunology Research

fig5

Figure 5

Figure 5: Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis 

Figure 5 | Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis 